Verisante Technology, Inc. Named Top Technology and Life Sciences Company on the TSX Venture Top 50 2012 Ranking
15 Février 2012 - 4:05PM
Marketwired
Verisante Technology, Inc. (TSX
VENTURE:VRS)(OTCQX:VRSEF)(PINKSHEETS:VRSEF)(FRANKFURT:V3T) (the
"Company" or "Verisante"), a leader in cancer detection technology,
announced today that the Company has been named this year's top
ranking Technology and Life Sciences Company on the TSX Venture 50.
The TSX Venture Exchange's annual list of its top 50 emerging
publicly traded companies is a ranking of the strongest performers
from five industry sectors. Verisante ranked number one on the list
of top 10 leading Technology and Life Sciences companies for the
year. Companies are selected based on four equally weighted
criteria - return on investment, trading activity, market
capitalization growth, and analyst coverage. The results were
obtained from data to December 31, 2011.
As the top ranking Technology and Life Sciences Company,
Verisante has been invited to attend the TSX Venture 50 Spotlight
event on April 3, 2012 in Toronto, with an opportunity to present
to an audience comprised of portfolio managers, investment bankers,
research analysts and investment advisors.
"The number one ranking by the TSX Venture Exchange underscores
the breakthrough year the Company has had," said Thomas Braun,
President and CEO. "The approval of Verisante Aura for use in the
key Canadian, European and Australian markets and the industry
recognition our technologies have recently received demonstrate
that we are moving forward on our commitment to helping healthcare
providers save lives through the detection of some of the most
common forms of cancer."
Verisante Aura has also recently been awarded Popular Science
Magazine's "Best of What's New Award" for 2011, and Verisante Core
was named one of the top 10 cancer breakthroughs of 2011 by the
Canadian Cancer Society. In addition, the Company was named a
finalist for the 2011 Regional Awards for New Technology by the
Canadian Manufacturers & Exporters and the National Research
Council of Canada.
About Verisante Technology, Inc.
Verisante is a medical device company committed to
commercializing innovative systems for the early detection of
cancer. The Verisante Aura(TM) for skin cancer detection and the
Verisante Core(TM) series for lung, colon and cervical cancer
detection utilize a proprietary cancer detection platform while the
operating software and probe technology are unique to each device.
The cancer detection platform was developed by the BC Cancer Agency
and tested and refined at the Skin Care Centre at Vancouver General
Hospital. This exclusive platform technology allows Verisante to
develop and offer a range of compact, non-invasive cancer detection
devices that offer physicians immediate results for many of the
most common cancers. The Aura(TM) has been approved for sale in
Canada, Europe and Australia. The Core(TM) has not yet been
approved for sale.
Youtube: www.youtube.com/verisante
Twitter: www.twitter.com/verisante
Facebook: www.facebook.com/verisante
Forward Looking Statements
This release contains forward-looking statements, including, but
not limited to, statements regarding the future commercialization
of medical devices, the market demand for these products and the
proprietary protections the Company will obtain with regard to the
technology, all of which statements are subject to market risks,
and the possibility that the Company will not be able to obtain
patent protection or obtain sufficient customer demand. These
statements are made based upon current expectations and actual
results may differ from those projected due to a number of risks
and uncertainties.
The TSX Venture Exchange has neither approved nor disapproved of
the contents of this press release. Neither the TSX Venture
Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this press
release.
Contacts: Verisante Technology, Inc. Thomas Braun President
& CEO (604) 605-0507info@verisante.com www.verisante.com
Verisante Technology (CE) (USOTC:VRSEF)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Verisante Technology (CE) (USOTC:VRSEF)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024